Momentum has slowed for the second day in a row, but the tendency has been some late buying that produces a strong close. With overseas markets operating on Monday when the U.S. is closed, there may be a little reluctance to add new inventory.
Category: Medical Equipment
Why Luxottica Group and Essilor International Pair So Well Together
Tune in as the team covers the many ways in which these two European industry leaders complement each other, from their product lines to their balance sheets. 10 stocks we like better than Luxottica Group When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.
The Luxottica Essilor Mega-Merger: Company Overviews
In this segment of Industry Focus: Consumer Goods , Motley Fool analyst Vincent Shen provides some key background onfashion frames retailer Luxottica Group as the two companies seek to combine their businesses in a $50 billion deal. Learn more about their respective revenues, market share, product offerings, and positions within the industry.
Everything You Need to Know About Luxottica and Essilor’s $50 Billion Merger
Take two leading companies in the eyewear industry, combine them, and what do you get? In this case, say hello to EssilorLuxottica. In this episode of Industry Focus: Consumer Goods , Vincent Shen and Asit Sharma dig into the details behind this mega-deal.
Everything You Need to Know About Luxottica and Essilor’s $50 Billion Merger
Take two leading companies in the eyewear industry, combine them, and what do you get? In this case, say hello to EssilorLuxottica. In this episode of Industry Focus: Consumer Goods , Vincent Shen and Asit Sharma dig into the details behind this mega-deal.
ResMed: Cramer’s Top Takeaways
Jim Cramer takes a closer look at ResMed and its future as a medical-device maker focusing on sleep apnea and COPD. Did you miss last night’s “Mad Money” on CNBC ? If so, here are some of Jim Cramer’s top takeaways.
Why Telecom Equipment Giants Are Struggling, but Their Suppliers Are Thriving
Optical component makers are enjoying the best business conditions they’ve arguably seen since the halcyon days of the dot-com bubble. But the same clearly can’t be said for many of the companies that have traditionally been their biggest clients.
Luxottica to join with Essilor in $70B merger of two eyewear giants
A global eyewear colossus worth almost $70 billion Canadian is set to be created as Italy’s Luxottica – owner of Ray-Ban and Oakley glasses – merges with France’s Essilor, owner of Crizal, Transitions, Clearly Contacts and other brands. Essilor said it had reached an agreement with Luxottica’s owners for an all-share deal to combine the two lens companies.
Luxottica and Essilor Create Eyewear Giant in $49B Deal
Italy’s Luxottica and France’s Essilor have agreed a 46 billion euro merger to create a global powerhouse in the eyewear industry with annual revenue of more than 15 billion euros, they said in a statement on Monday. The deal, one of Europe’s largest cross-border tie-ups, brings together Luxottica, the world’s top spectacles maker with brands such as Oakley and Ray-Ban, with Essilor, the world’s leading manufacturer of ophthalmic lenses.
Luxottica and Essilor to Merger in Near $50 billion Blockbuster Eyewear Deal
Luxottica Group and Essilor International said Monday that they would merge, creating an eyewear giant with combined revenues of nearly $16 billion. Luxottica Group SpA and Essilor International SA said Monday that they would merge, creating an eyewear giant with combined revenues of over a 15 billion .
Tiffany Gains as Wells Fargo Sees Improved Luxury Good Demand
Tiffany stock rose 1.70% to $81.92 in Friday’s trading session after Wells Fargo upgraded shares to “market perform” from “underperform” on signs of improving demand for luxury goods. The firm pointed to Richemont’s better-than-expected third-quarter sales , noting that the global luxury retail market appears to have bottomed in the first half of 2016.
Boston Scientific’s Upgrade May Lead to Breakout
We concluded, “This long-term Point and Figure chart, above, shows a long decline, a base and a recovery. A move above $24 on this chart opens the way for a $31 price target.
Tiffany Shares Surged Alongside Luxury Retailers on Richemont’s 3Q Sales
Earlier today, the Swiss jeweler and watchmaker said revenue rose 5% in constant currency to 3.09 billion euros for the three months ended December 31. Jewelry revenue was up 8% to 1.75 billion euros for the period, topping estimates for a 1.2% gain. “The cross-read of these results will probably benefit the other luxury names, in particular Swatch,” Bernstein analysts wrote today, according to the Wall Street Journal .
ICU Medical Shares Keep Climbing As BlackRock Ups Stake To More Than 10%
ICU Medical Inc. shares continued climbing in the extended session Monday after BlackRock Inc. disclosed earlier it had increased its stake in the medical device maker to more than 10%. ICU Medical shares surged 15% to $158.05 after hours, after closing up 4.3% in the regular session.
Daily Dividend Report: ENB, PBA, CNP, COG, COO, SKT
Enbridge declared a quarterly dividend of $0.583 per common share, payable on March 1, 2017 to shareholders of record on February 15, 2017. The declared dividend represents a 10 percent increase from the prior quarterly rate and the twenty-second consecutive year in which the Company has increased its common share dividend.
Analysts’ Actions — Medtronic, Nokia, Paccar, Verizon and More
AmerisourceBergen was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: ABC .